Finance

Lists
RCUS:NYSE
Arcus Biosciences Inc
USD 22,14
+0,09%
(+0,020) 1D
USD 22,14
0,00% (0,00)
After hours
Closed: 19 Okt., 16:00:05 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for RCUS...
Open
USD 22,44
High
USD 22,94
Low
USD 21,37
Mkt. cap
2,82 mjd
Avg. vol.
1,62 m
Volume
3,52 m
52-wk high
USD 31,74
52-wk low
USD 16,35
EPS
-USD 3,90
Beta
0,94
Shares outstanding
127,33 m
No. of employees
601
Open
USD 22,44
High
USD 22,94
Low
USD 21,37
Mkt. cap
2,82 mjd
Avg. vol.
1,62 m
Volume
3,52 m
52-wk high
USD 31,74
52-wk low
USD 16,35
EPS
-USD 3,90
Beta
0,94
Shares outstanding
127,33 m
No. of employees
601
News stories
From web sources and news partners
About Arcus Biosciences Inc
CEO-
Employees601
Founded2015
Headquarters-
Sector-
Analyst ratings
Based on 13 analysts giving stock ratings to RCUS in the past 3 months
Strong buy
Buy
10
Hold
3
Sell
0
12-month forecast
Based on 13 Wall Street analysts offering 12 month price targets for RCUS in the last 3 months.
Highest
Current USD 22,14
USD 50,00 (+125,84%)
Average
USD 39,75 (+79,54%)
Lowest
USD 23,00 (+3,88%)
Analyst
Recommendation
Action
Price target
Projected
Date
Richard Law CFA
Goldman Sachs
Buy
Maintained
USD 42,00
+89,7%
10/19/2026
Unknown Analyst
William Blair
Buy
Initiated
USD 50,00
+125,8%
10/15/2026
Priyanka Grover
J.P. Morgan
Buy
Initiated
USD 41,00
+85,2%
10/14/2026
Jason Zemansky
Bank of America Securities
Hold
Maintained
USD 29,00
+31%
10/05/2026
Charles Zhu
LifeSci Capital
Buy
Maintained
USD 46,00
+107,8%
10/03/2026
Robert Driscoll
Wedbush
Buy
Maintained
USD 43,00
+94,2%
09/30/2026
Emily Bodnar
H.C. Wainwright
Buy
Maintained
USD 45,00
+103,3%
09/25/2026
Tara Bancroft
TD Cowen
Buy
Initiated
-
-
09/16/2026
Yigal Nochomovitz
Citi
Buy
Maintained
USD 45,00
+103,3%
09/09/2026
Supawat Thongthip
Truist Financial
Buy
Reiterated
USD 40,00
+80,7%
09/08/2026
Terence Flynn
Morgan Stanley
Hold
Reiterated
USD 23,00
+3,9%
08/10/2026
Salim Syed
Mizuho Securities
Buy
Maintained
USD 47,00
+112,3%
08/05/2026
Eva Fortea Verdejo
Wells Fargo
Hold
Reiterated
USD 26,00
+17,4%
08/06/2026
Unknown Analyst
Mizuho Securities
Buy
Maintained
USD 47,00
+112,3%
06/10/2026
Gregory Renza
Truist Financial
Buy
Initiated
USD 35,00
+58,1%
05/18/2026
Daina Graybosch
Leerink Partners
Buy
Maintained
USD 47,00
+112,3%
04/20/2026
Jonathan Miller
Evercore ISI
Buy
Maintained
-
-
03/02/2026
Asthika Goonewardene
Truist Financial
Buy
Reiterated
USD 30,00
+35,5%
02/27/2026
Last report
05 Aug. 2026
Fiscal period
Q2 2026
-USD 0,72 / -USD 0,81
+11,58%beat
Revenue / Est. (USD)
41,00 m / 21,98 m
+86,52%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
26,00 m
33,00 m
17,00 m
41,00 m
Cost of goods sold
141,00 m
121,00 m
122,00 m
113,00 m
Cost of revenue
141,00 m
121,00 m
122,00 m
113,00 m
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
27,00 m
26,00 m
29,00 m
24,00 m
Operating expense
27,00 m
26,00 m
29,00 m
24,00 m
Total operating expenses
168,00 m
147,00 m
151,00 m
137,00 m
Operating income
-142,00 m
-114,00 m
-134,00 m
-96,00 m
Other non operating income
-
-
-
-
EBT including unusual items
-135,00 m
-106,00 m
-128,00 m
-91,00 m
EBT excluding unusual items
-135,00 m
-106,00 m
-128,00 m
-91,00 m
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-135,00 m
-106,00 m
-128,00 m
-91,00 m
Net profit margin
-519,23%
-321,21%
-752,94%
-221,95%
Earnings per share
-1,27
-0,89
-1,02
-0,72
Interest and investment income
10,00 m
10,00 m
9,00 m
8,00 m
Interest expense
-3,00 m
-2,00 m
-3,00 m
-3,00 m
Net interest expenses
7,00 m
8,00 m
6,00 m
5,00 m
Depreciation and amortization charges
-
-
-
-
EBITDA
-140,00 m
-111,00 m
-132,00 m
-93,00 m
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google-programme